Explore: Series A · France · Ireland · Portugal
Lucis
Series A · 🇫🇷 Paris, France · Founded 2025 · 1-10 employees
AI-driven preventive healthcare platform combining biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect health risks earlier. Lucis is a healthtech and deeptech startup based in Paris, France, founded 2025, at Series A stage, with $38.8M raised to date.
Lucis is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.
Total raised
$38.8M
Stage
Series A
Business model
SaaS
Key differentiator
It combines comprehensive biomarker testing, AI analysis, and physician review to convert routine blood tests into ongoing preventive health guidance.
Target customer
Consumers seeking preventive health screening and personalized health guidance
Sectors
Funding rounds
Key investors
General Catalyst, Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, North South Ventures
Notable achievements
- Raised $8.5M seed funding
- Served 3,000 customers
- Conducted over 500,000 clinical tests
- Built a network of 400+ European laboratories
Frequently asked questions
- What does Lucis do?
- AI-driven preventive healthcare platform combining biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect health risks earlier.
- Where is Lucis based?
- Lucis is based in Paris, France, founded in 2025.
- How much has Lucis raised?
- Lucis has raised $38.8M in tracked funding and is currently at the series-a stage.
- Who has invested in Lucis?
- Investors in Lucis include General Catalyst, Y Combinator, Kima Ventures, Motier Ventures, Circle.Co and North South Ventures.